These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29200846)

  • 21. Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-
    Du Y; Liang X; Li Y; Sun T; Jin Z; Xue H; Tian J
    Mol Pharm; 2017 Nov; 14(11):3978-3986. PubMed ID: 29016143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250.
    Muselaers CH; Rijpkema M; Bos DL; Langenhuijsen JF; Oyen WJ; Mulders PF; Oosterwijk E; Boerman OC
    J Urol; 2015 Aug; 194(2):532-8. PubMed ID: 25686542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoimaging and targeting treatment in an immunocompetent murine model of triple-negative breast cancer using radiolabeled anti-programmed death-ligand 1 monoclonal antibody.
    Pang X; Liu M; Wang R; Liao X; Yan P; Zhang C
    J Labelled Comp Radiopharm; 2018 Sep; 61(11):826-836. PubMed ID: 29923634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.
    Sonn GA; Behesnilian AS; Jiang ZK; Zettlitz KA; Lepin EJ; Bentolila LA; Knowles SM; Lawrence D; Wu AM; Reiter RE
    Clin Cancer Res; 2016 Mar; 22(6):1403-12. PubMed ID: 26490315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors.
    Chatterjee S; Lesniak WG; Gabrielson M; Lisok A; Wharram B; Sysa-Shah P; Azad BB; Pomper MG; Nimmagadda S
    Oncotarget; 2016 Mar; 7(9):10215-27. PubMed ID: 26848870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel intraoperative near-infrared fluorescence camera system for optical image-guided cancer surgery.
    Mieog JS; Vahrmeijer AL; Hutteman M; van der Vorst JR; Drijfhout van Hooff M; Dijkstra J; Kuppen PJ; Keijzer R; Kaijzel EL; Que I; van de Velde CJ; Löwik CW
    Mol Imaging; 2010 Aug; 9(4):223-31. PubMed ID: 20643025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.
    Lütje S; Rijpkema M; Goldenberg DM; van Rij CM; Sharkey RM; McBride WJ; Franssen GM; Frielink C; Helfrich W; Oyen WJ; Boerman OC
    Cancer Res; 2014 Nov; 74(21):6216-23. PubMed ID: 25252911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery.
    Ofori LO; Withana NP; Prestwood TR; Verdoes M; Brady JJ; Winslow MM; Sorger J; Bogyo M
    ACS Chem Biol; 2015 Sep; 10(9):1977-88. PubMed ID: 26039341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography Results in Negative Surgical Margins and Decreased Local Recurrence in an Orthotopic Mouse Model of Osteosarcoma.
    Mahjoub A; Morales-Restrepo A; Fourman MS; Mandell JB; Feiqi L; Hankins ML; Watters RJ; Weiss KR
    Ann Surg Oncol; 2019 Mar; 26(3):894-898. PubMed ID: 30588559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody.
    Guo X; Li C; Jia X; Qu Y; Li M; Cao C; Zhang Z; Qu Q; Luo S; Tang J; Liu H; Hu Z; Tian J
    EBioMedicine; 2023 Mar; 89():104476. PubMed ID: 36801616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
    Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
    Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using
    de Gooyer JM; Elekonawo FMK; Bos DL; van der Post RS; Pèlegrin A; Framery B; Cailler F; Vahrmeijer AL; de Wilt JHW; Rijpkema M
    Clin Cancer Res; 2020 Nov; 26(22):5934-5942. PubMed ID: 32900795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.
    Harlaar NJ; Koller M; de Jongh SJ; van Leeuwen BL; Hemmer PH; Kruijff S; van Ginkel RJ; Been LB; de Jong JS; Kats-Ugurlu G; Linssen MD; Jorritsma-Smit A; van Oosten M; Nagengast WB; Ntziachristos V; van Dam GM
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):283-290. PubMed ID: 28404198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.
    van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF
    BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
    Tummers QR; Hoogstins CE; Gaarenstroom KN; de Kroon CD; van Poelgeest MI; Vuyk J; Bosse T; Smit VT; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
    Oncotarget; 2016 May; 7(22):32144-55. PubMed ID: 27014973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.
    Moore LS; Rosenthal EL; de Boer E; Prince AC; Patel N; Richman JM; Morlandt AB; Carroll WR; Zinn KR; Warram JM
    Mol Imaging Biol; 2017 Aug; 19(4):610-616. PubMed ID: 27830425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing fresh specimen staining for rapid identification of tumor biomarkers during surgery.
    Barth CW; Schaefer JM; Rossi VM; Davis SC; Gibbs SL
    Theranostics; 2017; 7(19):4722-4734. PubMed ID: 29187899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
    Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
    Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
    Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.